ArticleFrontiers in neurology2025
Development of a radiomics-based model for diagnosis of multiple system atrophy using multimodal MRI.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multiple system atrophy (MSA) is a rapidly progressive neuro-degenerative disorder characterized by autonomic dysfunction, levodopa- unresponsive parkinsonism, cerebellar ataxia, and corticospinal tract involvement. Early diagnosis remains challenging due to overlapping clinical manifestations and the absence of reliable biomarkers. This study aimed to develop a radiomics-based diagnostic model using multimodal MRI to improve MSA detection. Methods: A retrospective cohort of 62 clinically probable MSA patients (per the 2022 Movement Disorder Society criteria), and 73 matched healthy controls underwent 3.0-T MRI (T1WI, T2WI, FLAIR, DWI). Seven brain regions (bilateral cerebellar hemispheres, middle cerebellar peduncles, putamen, and pons) were manually segmented. A total of 1,502 radiomics features were extracted per region, using PyRadiomics (IBSI-compliant). Features with an intraclass correlation coefficient (ICC) ≥ 0.75 were retained, and the least absolute shrinkage and selection operator (LASSO) regression identified the top discriminative features to construct region-specific radiomics scores (Rad-scores). A logistic regression (LR) model integrated Rad-scores from all regions. Model performance was evaluated via precision, recall, and F1-score in training, testing, and validation cohorts (split ratio 6:2:2), and compared with visual assessments by two radiologists. Results: The LR model achieved high performance: accuracy was 0.98 in the training cohort, 0.97 in the testing cohort, and 0.95 in the validation cohort. Notably, classification precision for MSA reached 1.0 (indicating no false positives) across all cohorts. SHapley Additive exPlanations (SHAP) analysis revealed that the left putamen Rad-score as the most influential predictor. The model significantly outperformed radiologists' visual assessments (radiologist AUCs: 0.559 and 0.535; Conclusion: Multimodal MRI radiomics accurately differentiates MSA from healthy controls, even in the absence of conventional MRI markers. The Rad-score model demonstrates high sensitivity (89% recall in the validation cohort) and perfect specificity (100% precision), providing a clinically actionable tool for early MSA diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.